Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2019

Open Access 01-12-2019 | Influenza | Research article

Hospital-acquired influenza in an Australian tertiary Centre 2017: a surveillance based study

Authors: Nikita Parkash, Wendy Beckingham, Patiyan Andersson, Paul Kelly, Sanjaya Senanayake, Nicholas Coatsworth

Published in: BMC Pulmonary Medicine | Issue 1/2019

Login to get access

Abstract

Background

In 2017, Australia experienced its highest levels of influenza virus activity since the 2009 pandemic. This allowed detailed comparison of the characteristics of patients with community and hospital-acquired influenza, and infection control factors that contributed to influenza spread.

Methods

A surveillance based study was conducted on hospitalised patients with laboratory-confirmed influenza at the Canberra Hospital during April–October 2017. Differences between the hospital-acquired and community-acquired patient characteristics and outcomes were assessed by univariate analysis. Epidemiologic curves were developed and cluster distribution within the hospital was determined.

Results

Two hundred and ninety-two patients were included in the study. Twenty-eight (9.6%) acquired influenza in hospital, representing a higher proportion than any of the previous 5 years (range 0.9–5.8%). These patients were more likely to have influenza A (p = 0.021), had higher rates of diabetes (p = 0.015), malignancy (p = 0.046) and chronic liver disease (p = 0.043). Patients acquiring influenza in hospital met clinical criteria for influenza like illness in 25% of cases, compared with 64.4% for community-acquired cases (p < 0.001). Hospital-acquired influenza cases occurred in two distinct clusters. Patients were moved an average of 5 times after diagnosis. Mean length of stay following diagnosis was 13 days compared to 5 days for community-acquired cases (p < 0.001). Of the patients with hospital-acquired influenza, 22 were in shared rooms during their incubation period and 9 were not isolated in single rooms following diagnosis. Treatment was initiated within the recommended 48 h period following symptom onset for 62.5% of hospital-acquired cases compared with 39.8% of community-acquired cases (p = 0.033).

Conclusions

Our results show that clinical presentation differed between patients with hospital-acquired influenza compared with those who acquired influenza in the community. Cases occurred in two clusters suggesting intra-hospital transmission rather than random importation from the community, highlighting the importance of infection control measures to limit influenza spread. Patients with hospital-acquired influenza may present without classical features of an influenza-like illness and this should promote earlier diagnostic testing and isolation to limit spread. Movement of patients after diagnosis is likely to facilitate spread within the hospital.
Literature
2.
go back to reference Salgado CD, Farr BM, Hall KK, Hayden FG. Influenza in the acute hospital setting. Lancet Infect Dis. 2002;2:145–55.CrossRef Salgado CD, Farr BM, Hall KK, Hayden FG. Influenza in the acute hospital setting. Lancet Infect Dis. 2002;2:145–55.CrossRef
3.
go back to reference Huzly D, Kurz S, Ebner W, Dettenkofer M, Panning M. Characterisation of nosocomial and community-acquired influenza in a large university hospital during two consecutive influenza seasons. J Clin Virol. 2015;73:47–51.CrossRef Huzly D, Kurz S, Ebner W, Dettenkofer M, Panning M. Characterisation of nosocomial and community-acquired influenza in a large university hospital during two consecutive influenza seasons. J Clin Virol. 2015;73:47–51.CrossRef
4.
go back to reference Jhung MA, D'Mello T, Pérez A, Aragon D, Bennett NM, Cooper T, et al. Hospital-onset influenza hospitalizations—United States, 2010-2011. Am J Infect Control. 2014;42:7–11.CrossRef Jhung MA, D'Mello T, Pérez A, Aragon D, Bennett NM, Cooper T, et al. Hospital-onset influenza hospitalizations—United States, 2010-2011. Am J Infect Control. 2014;42:7–11.CrossRef
5.
go back to reference Macesic N, Kotsimbos TC, Kelly P, Cheng AC. Hospital-acquired influenza in an Australian sentinel surveillance system. Med J Aust. 2013;198:370–2.CrossRef Macesic N, Kotsimbos TC, Kelly P, Cheng AC. Hospital-acquired influenza in an Australian sentinel surveillance system. Med J Aust. 2013;198:370–2.CrossRef
6.
go back to reference Taylor G, Mitchell R, McGeer A, Frenette C, Suh KN, Wong A, et al. Healthcare-associated influenza in Canadian hospitals from 2006 to 2012. Infect Control Hosp Epidemiol. 2014;35:169–75.CrossRef Taylor G, Mitchell R, McGeer A, Frenette C, Suh KN, Wong A, et al. Healthcare-associated influenza in Canadian hospitals from 2006 to 2012. Infect Control Hosp Epidemiol. 2014;35:169–75.CrossRef
7.
go back to reference Álvarez-Lerma F, Marín-Corral J, Vilà C, Masclans JR, Loeches IM, Barbadillo S, et al. Characteristics of patients with hospital-acquired influenza a (H1N1)pdm09 virus admitted to the intensive care unit. J Hosp Infect. 2017;95:200–6.CrossRef Álvarez-Lerma F, Marín-Corral J, Vilà C, Masclans JR, Loeches IM, Barbadillo S, et al. Characteristics of patients with hospital-acquired influenza a (H1N1)pdm09 virus admitted to the intensive care unit. J Hosp Infect. 2017;95:200–6.CrossRef
8.
go back to reference Vanhems P, Benet T, Munier-Marion E. Nosocomial influenza: encouraging insights and future challenges. Curr Opin Infect Dis. 2016;29:366–72.CrossRef Vanhems P, Benet T, Munier-Marion E. Nosocomial influenza: encouraging insights and future challenges. Curr Opin Infect Dis. 2016;29:366–72.CrossRef
9.
go back to reference Weedon KM, Rupp AH, Heffron AC, Kelly SF, Zheng X, Shulman ST, et al. The impact of infection control upon hospital-acquired influenza and respiratory syncytial virus. Scan J Infect Dis. 2013;45:297–303.CrossRef Weedon KM, Rupp AH, Heffron AC, Kelly SF, Zheng X, Shulman ST, et al. The impact of infection control upon hospital-acquired influenza and respiratory syncytial virus. Scan J Infect Dis. 2013;45:297–303.CrossRef
11.
go back to reference Flannery B, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, et al. Interim estimates of 2017-18 seasonal influenza vaccine effectiveness - United States, February 2018. MMWR Morb Mortal Wkly Rep. 2018;67:180–5.CrossRef Flannery B, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, et al. Interim estimates of 2017-18 seasonal influenza vaccine effectiveness - United States, February 2018. MMWR Morb Mortal Wkly Rep. 2018;67:180–5.CrossRef
12.
go back to reference Kelly PM, Kotsimbos T, Reynolds A, Wood-Baker R, Hancox B, Brown SGA, et al. FluCAN 2009: initial results from sentinel surveillance for adult influenza and pneumonia in eight Australian hospitals. Med J Aust. 2011;194:169–74.PubMed Kelly PM, Kotsimbos T, Reynolds A, Wood-Baker R, Hancox B, Brown SGA, et al. FluCAN 2009: initial results from sentinel surveillance for adult influenza and pneumonia in eight Australian hospitals. Med J Aust. 2011;194:169–74.PubMed
13.
go back to reference Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DAT. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009;9:291–300.CrossRef Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DAT. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009;9:291–300.CrossRef
14.
go back to reference Munier-Marion E, Bénet T, Vanhems P. Definition of healthcare-associated influenza: a review and results from an international survey. Influenza Other Respir Viruses. 2017;11:367–71.CrossRef Munier-Marion E, Bénet T, Vanhems P. Definition of healthcare-associated influenza: a review and results from an international survey. Influenza Other Respir Viruses. 2017;11:367–71.CrossRef
16.
go back to reference Munier-Marion E, Benet T, Regis C, Lina B, Morfin F, Vanhems P. Hospitalization in double-occupancy rooms and the risk of hospital-acquired influenza: a prospective cohort study. Clin Microbiol Infect. 2016;22:461.e7–9.CrossRef Munier-Marion E, Benet T, Regis C, Lina B, Morfin F, Vanhems P. Hospitalization in double-occupancy rooms and the risk of hospital-acquired influenza: a prospective cohort study. Clin Microbiol Infect. 2016;22:461.e7–9.CrossRef
17.
go back to reference Ip DKM, Lau LLH, Chan K-H, Fang VJ, Leung GM, Peiris MJS, et al. The dynamic relationship between clinical symptomatology and viral shedding in naturally acquired seasonal and pandemic influenza virus infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 62; 2016. p. 431–7. Ip DKM, Lau LLH, Chan K-H, Fang VJ, Leung GM, Peiris MJS, et al. The dynamic relationship between clinical symptomatology and viral shedding in naturally acquired seasonal and pandemic influenza virus infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 62; 2016. p. 431–7.
18.
go back to reference Goins WP, Talbot HK, Talbot TR. Health care–acquired viral respiratory diseases. Infect Dis Clin N Am. 2011;25:227–44.CrossRef Goins WP, Talbot HK, Talbot TR. Health care–acquired viral respiratory diseases. Infect Dis Clin N Am. 2011;25:227–44.CrossRef
19.
go back to reference Hagel S, Ludewig K, Moeser A, Baier M, Loffler B, Schleenvoigt B, et al. Characteristics and management of patients with influenza in a German hospital during the 2014/2015 influenza season. Infection. 2016;44:667–72.CrossRef Hagel S, Ludewig K, Moeser A, Baier M, Loffler B, Schleenvoigt B, et al. Characteristics and management of patients with influenza in a German hospital during the 2014/2015 influenza season. Infection. 2016;44:667–72.CrossRef
20.
go back to reference Janet AE, Richard EC, Philip RW, Hagop K, Atmar RL, Jeffrey T, et al. Common emergence of amantadine- and Rimantadine-resistant influenza a viruses in symptomatic immunocompromised adults. Clin Infect Dis. 1998;26:1418–24.CrossRef Janet AE, Richard EC, Philip RW, Hagop K, Atmar RL, Jeffrey T, et al. Common emergence of amantadine- and Rimantadine-resistant influenza a viruses in symptomatic immunocompromised adults. Clin Infect Dis. 1998;26:1418–24.CrossRef
21.
go back to reference Eveillard M, Quenon J-L, Rufat P, Mangeol A, Fauvelle F. Association between hospital-acquired infections and patients' transfers. Infect Control Hosp Epidemiol. 2001;22:693–6.CrossRef Eveillard M, Quenon J-L, Rufat P, Mangeol A, Fauvelle F. Association between hospital-acquired infections and patients' transfers. Infect Control Hosp Epidemiol. 2001;22:693–6.CrossRef
22.
go back to reference De Angelis G, Murthy A, Beyersmann J, Harbarth S. Estimating the impact of healthcare-associated infections on length of stay and costs. Clin Microbiol Infect. 2010;16:1729–35.CrossRef De Angelis G, Murthy A, Beyersmann J, Harbarth S. Estimating the impact of healthcare-associated infections on length of stay and costs. Clin Microbiol Infect. 2010;16:1729–35.CrossRef
23.
go back to reference Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal influenza in adults and children - diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1003–32.CrossRef Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal influenza in adults and children - diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1003–32.CrossRef
24.
go back to reference Ng S, Cowling BJ, Fang VJ, Chan KH, Ip DKM, Cheng CKY, et al. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis. 2010;50:707–14.CrossRef Ng S, Cowling BJ, Fang VJ, Chan KH, Ip DKM, Cheng CKY, et al. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis. 2010;50:707–14.CrossRef
25.
go back to reference Sullivan SG, Chilver MB, Carville KS, Deng Y-M, Grant KA, Higgins G, et al. Low interim influenza vaccine effectiveness, Australia, 1 may to 24 September 2017. Euro Surveill. 2017;22:2–8. Sullivan SG, Chilver MB, Carville KS, Deng Y-M, Grant KA, Higgins G, et al. Low interim influenza vaccine effectiveness, Australia, 1 may to 24 September 2017. Euro Surveill. 2017;22:2–8.
27.
go back to reference Voirin N, Payet C, Barrat A, Cattuto C, Khanafer N, Régis C, et al. Combining high-resolution contact data with virological data to investigate influenza transmission in a tertiary care hospital. Infect Control Hosp Epidemiol. 2015;36:254–60.CrossRef Voirin N, Payet C, Barrat A, Cattuto C, Khanafer N, Régis C, et al. Combining high-resolution contact data with virological data to investigate influenza transmission in a tertiary care hospital. Infect Control Hosp Epidemiol. 2015;36:254–60.CrossRef
28.
go back to reference Houlihan CF, Frampton D, Ferns RB, Raffle J, Grant P, Reidy M, et al. Use of whole-genome sequencing in the investigation of a nosocomial influenza virus outbreak. J Infect Dis. 2018;218:1485–9.CrossRef Houlihan CF, Frampton D, Ferns RB, Raffle J, Grant P, Reidy M, et al. Use of whole-genome sequencing in the investigation of a nosocomial influenza virus outbreak. J Infect Dis. 2018;218:1485–9.CrossRef
Metadata
Title
Hospital-acquired influenza in an Australian tertiary Centre 2017: a surveillance based study
Authors
Nikita Parkash
Wendy Beckingham
Patiyan Andersson
Paul Kelly
Sanjaya Senanayake
Nicholas Coatsworth
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Influenza
Published in
BMC Pulmonary Medicine / Issue 1/2019
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-019-0842-6

Other articles of this Issue 1/2019

BMC Pulmonary Medicine 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine